News

News Center

Xi Jinping: Advanced treatment methods such as convalescent plasma, stem cells, and monoclonal antibodies should be adopted to enhance the management of severe and critically ill patients.

2020-03-03

CCTV's "Xinwen Lianbo" reported that on the afternoon of March 2, Xi Jinping visited the Academy of Military Medical Sciences and the School of Medicine at Tsinghua University one after another. He inspected the scientific research efforts and clinical treatment initiatives aimed at tackling the COVID-19 pandemic, reviewed the progress in developing vaccines, antibodies, pharmaceuticals, and rapid-testing products, and learned about their practical applications. During his visits, he also extended greetings and encouragement to experts and researchers. Later, he chaired a symposium to listen to insights and suggestions from officials in charge of relevant departments as well as from the scientific community. At the meeting, he emphasized the need to adopt advanced treatment methods such as convalescent plasma, stem cells, and monoclonal antibodies to improve the management of severe and critically ill patients.

Xi Jinping emphasized that doing everything possible to save more patients' lives is the top priority and immediate task. He stressed the need to strengthen the integration of drug and medical equipment development with clinical treatment, effectively improving recovery rates while reducing mortality. Furthermore, he called for bolstering scientific research efforts to support and serve frontline treatment, ensuring close collaboration between clinical research and patient care, and directing more research outcomes toward practical applications on the frontlines. Efforts should also accelerate the development of new drugs, adhering to an integrated approach that combines traditional Chinese medicine with Western medicine and utilizes both types of therapies simultaneously. This includes speeding up the widespread adoption of already-developed and promising treatments, while also identifying additional effective therapeutic options tailored to the needs of frontline care. Ultimately, the goal is to explore innovative treatment methods and minimize the progression from mild to severe cases as much as possible. Advanced treatment approaches such as convalescent plasma, stem cells, and monoclonal antibodies should be adopted to enhance the management of severe and critically ill patients.

Science and Technology Daily: How Can Stem Cells Help Fight the Pandemic?

Do you know about these rare diseases that have gained fame online?

Here is the title—h1 placeholder text

Online Message

COOKIES

Our website uses cookies and similar technologies to personalize the advertising shown to you and to help you get the best experience on our website. For more information, see our Privacy & Cookie Policy

COOKIES

required

These cookies are necessary for basic functions such as payment. Standard cookies cannot be turned off and do not store any of your information.

analyze

These cookies collect information, such as how many people are using our site or which pages are popular, to help us improve the customer experience. Turning these cookies off will mean we can't collect information to improve your experience.

Feature

These cookies enable the website to provide enhanced functionality and personalization. They may be set by us or by third-party providers whose services we have added to our pages. If you do not allow these cookies, some or all of these services may not function properly.

advertise

These cookies help us understand what you are interested in so that we can show you relevant advertising on other websites. Turning these cookies off will mean we are unable to show you any personalized advertising.

Business license